Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Patient Stories » Allison, W.A.

Allison, W.A.

“I feel incredibly lucky it was found when it was.”

In August 2024, I took part in the routine bowel cancer screening program — the test kit that arrives in the mail when you turn 50. One of my samples, which I took while I was constipated, showed a small trace of blood. The other was clear. I didn’t think too much of it at the time — I felt healthy and had no major symptoms — but I booked in for a colonoscopy just to be safe.

That colonoscopy turned out to be life-saving.

During the procedure, the specialist found seven polyps, mild diverticulitis, and — most unexpectedly — a lump in my small intestine, not too far in. I was called back the following week and told I had a small, well-differentiated Grade 1 Neuroendocrine Tumour (NET). I was shocked. I’d never even heard of NETs before.

From that moment, everything moved swiftly. I had a 24-hour urine test, multiple rounds of blood work, a CT scan, a nuclear scan, and an MRI. Every step was clearly explained, and I felt confident that my health care team were following the gold standard in NET management.

Four months later, a second colonoscopy showed the tumour was embedded in the lining of my small intestine. After discussing my options, I made the decision to have a surgical resection to remove it. Thankfully, the surgery was successful. Pathology results showed no remaining cancer markers, and I didn’t need chemotherapy or radiation.

Now, I continue with follow-up care — a yearly nuclear scan and blood tests, with the option to increase to every six months if I feel more comfortable. My specialist is supportive and attentive to what I need to feel confident in my monitoring plan.

I often reflect on how fortunate I am. If I hadn’t done that test — or if my specialist hadn’t been so thorough — this tumour could have quietly progressed. But thanks to early detection, timely intervention, and health care professionals who followed the Optimal Care Pathway for Neuroendocrine Tumours, my outcome is entirely different.

This experience has made me a firm believer in screening, early diagnosis, and specialist NET care. I feel incredibly lucky — and grateful — that my NET was found at such an early, treatable stage.

Patient Stories

Cassie, QLD

I’m a 36-year-old mum of three little humans – things like this just doesn’t happen to people like me. Until all of a sudden it does, and everything changes

Lana, NSW

Blurry vision had led to a diagnosis of Von Hippel-Lindau (VHL) disease – a condition where multiple tumours grow in various parts of the body, including the brain, spinal cord, abdominal organs, and eyes.

Simon, VIC

We need greater awareness of VHL, better education for healthcare professionals, and up-to-date resources to guide patients through diagnosis and care.

Vanessa, ACT

I was in my late twenties when I first realised something wasn’t right. I began experiencing numbness in my back, and after months of tests and uncertainty, doctors discovered a cluster of tumours in my spine. That’s when I was diagnosed with VHL.

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin